✦ LIBER ✦

Left Main (LM) Coronary Stenting in Patients Without Previous Coronary Bypass Surgery: The Auckland City Hospital Experience

✍ Scribed by T. Glenie; F. De Vroey; P. Ruygrok; J. Ormiston; J. Stewart; M. Webster

Book ID: 116527494
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 64 KB
Volume: 20
Category: Article
ISSN: 1443-9506
DOI: 10.1016/j.hlc.2011.03.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Percutaneous Coronary Intervention for L

Percutaneous Coronary Intervention for Left Main (LM) Coronary Artery Stenosis in Patients Without Previous Coronary Bypass Surgery: The Auckland City Hospital Experience

✍ T. Glenie; F. De Vroey; P. Ruygrok; J. Ormiston; J. Stewart; M. Webster 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

IN-HOSPITAL AND ONE YEAR SURVIVAL OF PAT

IN-HOSPITAL AND ONE YEAR SURVIVAL OF PATIENTS UNDERGOING UNPROTECTED LEFT MAIN CORONARY ARTERY STENTING WHO ARE NOT CANDIDATES FOR CORONARY ARTERY BYPASS SURGERY

✍ Ng, William; Lundstrom, Robert; McNulty, Edward 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Everolimus-Eluting Stent Implantation fo

Everolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis: The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) Study

✍ Young-Hak Kim; Duk-Woo Park; Jung-Min Ahn; Sung-Cheol Yun; Hae Geun Song; Jong-Y 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 646 KB

One-Year Follow-Up of Nonrandomized Comp

One-Year Follow-Up of Nonrandomized Comparison between Coronary Artery Bypass Grafting Surgery and Drug-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease in Elderly Patients (Aged ≥75 Years)

✍ RABEH GHENIM; JÉRÔME RONCALLI; AMIR M. TIDJANE; VANINA BONGARD; ABDELKADER ZIANI 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Outcomes in Patients With De Novo Left M

Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

✍ Morice, M.-C.; Serruys, P. W.; Kappetein, A. P.; Feldman, T. E.; Stahle, E.; Col 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 583 KB